CRXL buyout: It’s amusing that the author of this graphic from two years ago considered CRXL a target of buyout interest from NVS, GSK, SNY, and MRK—i.e. just about everyone except JNJ.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.